Abafungin
cream) | |
ATC code |
|
---|---|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Abafungin (
dermatomycoses
.
Abasol is a topical cream formulation of abafungin by York Pharma.[1]
History
Abafungin was first synthesized at
H2-antagonists related to famotidine, resulted in the discovery of its antifungal properties.[2]
Its development seems to have been discontinued in 2009.[3]
Mechanism of action
Unlike imidazole- and triazole-class antifungals, abafungin directly impairs the fungal cell membrane.[2]
In addition, abafungin inhibits the enzyme sterol 24-C-methyltransferase, modifying the composition of the fungal membrane.[4]
Abafungin has antibiotic activity against gram-positive bacteria as well as sporicidal activity.[5]
References
- ^ "Regulatory Update – Abasol" (PDF). York Pharma. Archived from the original (PDF) on September 27, 2007.
- ^ PMID 18587237.
- ^ "Abafungin". AdisInsight. Retrieved 5 May 2021.
- PMID 8587237.
- ^ Ginter-Hanselmayer G (March 2009). Arbeitsunterlagen zur 42. wissenschaftlichen Fortbildungsveranstaltung für Apothekerinnen und Apotheker: Infektionskrankheiten. Österreichische Apothekerkammer. p. 103.
External links
- Media related to Abafungin at Wikimedia Commons